{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T01:37:39Z","timestamp":1768268259873,"version":"3.49.0"},"reference-count":98,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,8,5]],"date-time":"2023-08-05T00:00:00Z","timestamp":1691193600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2023,8,5]],"date-time":"2023-08-05T00:00:00Z","timestamp":1691193600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetes Ther"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s13300-023-01455-9","type":"journal-article","created":{"date-parts":[[2023,8,5]],"date-time":"2023-08-05T16:01:44Z","timestamp":1691251304000},"page":"1595-1607","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A Systematic Approach to Treating Early Metabolic Disease and Prediabetes"],"prefix":"10.1007","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8904-5034","authenticated-orcid":false,"given":"Nicholas W.","family":"Carris","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian E.","family":"Bunnell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahul","family":"Mhaskar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher G.","family":"DuCoin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marilyn","family":"Stern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,8,5]]},"reference":[{"key":"1455_CR1","doi-asserted-by":"publisher","DOI":"10.1161\/jaha.118.011295","volume":"8","author":"S Raghavan","year":"2019","unstructured":"Raghavan S, Vassy JL, Ho YL, et al. Diabetes mellitus-related all-cause and cardiovascular mortality in a national cohort of adults. J Am Heart Assoc. 2019;8: e011295. https:\/\/doi.org\/10.1161\/jaha.118.011295.","journal-title":"J Am Heart Assoc"},{"key":"1455_CR2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0239236","volume":"15","author":"C Lin","year":"2020","unstructured":"Lin C, Liu J, Sun H. Risk factors for lower extremity amputation in patients with diabetic foot ulcers: a meta-analysis. PLoS ONE. 2020;15:e0239236. https:\/\/doi.org\/10.1371\/journal.pone.0239236.","journal-title":"PLoS ONE"},{"key":"1455_CR3","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/j.mayocpiqo.2021.07.003","volume":"5","author":"CC Gao","year":"2021","unstructured":"Gao CC, Espinoza Suarez NR, Toloza FJK, et al. Patients\u2019 perspective about the cost of diabetes management: an analysis of online health communities. Mayo Clin Proc Innov Qual Outcomes. 2021;5:898\u2013906. https:\/\/doi.org\/10.1016\/j.mayocpiqo.2021.07.003.","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"key":"1455_CR4","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.2337\/dc23-S002","volume":"46","author":"NA ElSayed","year":"2023","unstructured":"ElSayed NA, Aleppo G, Aroda VR, et al. 2. Classification and diagnosis of diabetes: standards of care in diabetes-2023. Diabetes Care. 2023;46:S19\u201340. https:\/\/doi.org\/10.2337\/dc23-S002.","journal-title":"Diabetes Care"},{"key":"1455_CR5","doi-asserted-by":"publisher","first-page":"e93","DOI":"10.1161\/cir.0000000000001123","volume":"147","author":"CW Tsao","year":"2023","unstructured":"Tsao CW, Aday AW, Almarzooq ZI, et al. Heart disease and stroke statistics-2023 update: a report from the American Heart Association. Circulation. 2023;147:e93\u2013621. https:\/\/doi.org\/10.1161\/cir.0000000000001123.","journal-title":"Circulation"},{"key":"1455_CR6","doi-asserted-by":"publisher","first-page":"S41","DOI":"10.2337\/dc23-S003","volume":"46","author":"NA ElSayed","year":"2023","unstructured":"ElSayed NA, Aleppo G, Aroda VR, et al. 3. Prevention or delay of type\u00a02 diabetes and associated comorbidities: standards of care in diabetes-2023. Diabetes Care. 2023;46:S41\u20138. https:\/\/doi.org\/10.2337\/dc23-S003.","journal-title":"Diabetes Care"},{"key":"1455_CR7","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.eprac.2023.02.001","volume":"29","author":"SL Samson","year":"2023","unstructured":"Samson SL, Vellanki P, Blonde L, et al. American Association of Clinical Endocrinology Consensus Statement: comprehensive type\u00a02 diabetes management algorithm - 2023 update. Endocr Pract. 2023;29:305\u201340. https:\/\/doi.org\/10.1016\/j.eprac.2023.02.001.","journal-title":"Endocr Pract"},{"key":"1455_CR8","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1001\/jamainternmed.2016.6210","volume":"176","author":"RF Redberg","year":"2016","unstructured":"Redberg RF. The medicalization of common conditions. JAMA Intern Med. 2016;176:1863. https:\/\/doi.org\/10.1001\/jamainternmed.2016.6210.","journal-title":"JAMA Intern Med"},{"key":"1455_CR9","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1001\/jamainternmed.2016.5919","volume":"176","author":"S Shahraz","year":"2016","unstructured":"Shahraz S, Pittas AG, Kent DM. Prediabetes risk in adult Americans according to a risk test. JAMA Intern Med. 2016;176:1861\u20133. https:\/\/doi.org\/10.1001\/jamainternmed.2016.5919.","journal-title":"JAMA Intern Med"},{"key":"1455_CR10","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1016\/s0140-6736(17)30315-x","volume":"389","author":"OM Farr","year":"2017","unstructured":"Farr OM, Mantzoros CS. Treating prediabetes in the obese: are GLP-1 analogues the answer? Lancet. 2017;389:1371\u20132. https:\/\/doi.org\/10.1016\/s0140-6736(17)30315-x.","journal-title":"Lancet"},{"key":"1455_CR11","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1056\/NEJMoa012512","volume":"346","author":"WC Knowler","year":"2002","unstructured":"Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type\u00a02 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393\u2013403. https:\/\/doi.org\/10.1056\/NEJMoa012512.","journal-title":"N Engl J Med"},{"key":"1455_CR12","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1016\/s0140-6736(09)61457-4","volume":"374","author":"WC Knowler","year":"2009","unstructured":"Knowler WC, Fowler SE, Hamman RF, et al. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet. 2009;374:1677\u201386. https:\/\/doi.org\/10.1016\/s0140-6736(09)61457-4.","journal-title":"Lancet"},{"key":"1455_CR13","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1161\/circulationaha.121.056756","volume":"145","author":"RB Goldberg","year":"2022","unstructured":"Goldberg RB, Orchard TJ, Crandall JP, et al. Effects of long-term metformin and lifestyle interventions on cardiovascular events in the diabetes prevention program and its outcome study. Circulation. 2022;145:1632\u201341. https:\/\/doi.org\/10.1161\/circulationaha.121.056756.","journal-title":"Circulation"},{"key":"1455_CR14","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/s2213-8587(15)00291-0","volume":"3","author":"Diabetes Prevention Program Research Group","year":"2015","unstructured":"Diabetes Prevention Program Research Group. Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study. Lancet Diabetes Endocrinol. 2015;3:866\u201375. https:\/\/doi.org\/10.1016\/s2213-8587(15)00291-0.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1455_CR15","unstructured":"American Diabetes Association. New data from diabetes prevention program outcomes study shows persistent reduction of type\u00a02 diabetes development over 22-year average follow-up. https:\/\/diabetes.org\/newsroom\/press-releases\/2020\/new-data-from-diabetes-prevention-program-outcomes-study-shows-persistent-reduction-of-t2d-development-over-22-year-average-follow-up. Accessed 14 Jun 2023."},{"key":"1455_CR16","doi-asserted-by":"publisher","first-page":"723","DOI":"10.2337\/dc11-1468","volume":"35","author":"WHES Herman","year":"2012","unstructured":"Herman WHES, Ratner RE, Montez MG, et al. The 10-year cost-effectiveness of lifestyle intervention or metformin for diabetes prevention: an intent-to-treat analysis of the DPP\/DPPOS. Diabetes Care. 2012;35:723\u201330. https:\/\/doi.org\/10.2337\/dc11-1468.","journal-title":"Diabetes Care"},{"issue":"57","key":"1455_CR17","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.japh.2017.05.015","volume":"2017","author":"NW Carris","year":"2003","unstructured":"Carris NW, Cheng F, Kelly WN. The changing cost to prevent diabetes: a retrospective analysis of the Diabetes Prevention Program. J Am Pharm Assoc. 2003;2017(57):717\u201322. https:\/\/doi.org\/10.1016\/j.japh.2017.05.015.","journal-title":"J Am Pharm Assoc"},{"key":"1455_CR18","unstructured":"Centers for Medicare and Medicaid Services. Medicare Diabetes Prevention Program expansion. https:\/\/www.cms.gov\/Newsroom\/MediaReleaseDatabase\/Fact-sheets\/2016-Fact-sheets-items\/2016-07-07.html. Accessed 21 Jun 2018."},{"key":"1455_CR19","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1111\/dme.14286","volume":"37","author":"J Nano","year":"2020","unstructured":"Nano J, Carinci F, Okunade O, et al. A standard set of person-centred outcomes for diabetes mellitus: results of an international and unified approach. Diabet Med. 2020;37:2009\u201318. https:\/\/doi.org\/10.1111\/dme.14286.","journal-title":"Diabet Med"},{"key":"1455_CR20","doi-asserted-by":"publisher","first-page":"977","DOI":"10.2337\/diacare.26.4.977","volume":"26","author":"Diabetes Prevention Program Research Group","year":"2003","unstructured":"Diabetes Prevention Program Research Group. Effects of withdrawal from metformin on the development of diabetes in the diabetes prevention program. Diabetes Care. 2003;26:977\u201380. https:\/\/doi.org\/10.2337\/diacare.26.4.977.","journal-title":"Diabetes Care"},{"key":"1455_CR21","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2020-001537","author":"EA Walker","year":"2020","unstructured":"Walker EA, Gonzalez JS, Tripputi MT, et al. Long-term metformin adherence in the Diabetes Prevention Program Outcomes Study. BMJ Open Diabetes Res Care. 2020. https:\/\/doi.org\/10.1136\/bmjdrc-2020-001537.","journal-title":"BMJ Open Diabetes Res Care"},{"key":"1455_CR22","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1001\/jamainternmed.2016.2952","volume":"176","author":"G Spencer-Bonilla","year":"2016","unstructured":"Spencer-Bonilla G, Rodriguez-Gutierrez R, Montori VM. What we don\u2019t talk about when we talk about preventing type\u00a02 diabetes-addressing socioeconomic disadvantage. JAMA Intern Med. 2016;176:1053\u20134. https:\/\/doi.org\/10.1001\/jamainternmed.2016.2952.","journal-title":"JAMA Intern Med"},{"key":"1455_CR23","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.2105\/ajph.2013.301420","volume":"104","author":"DJ Gaskin","year":"2014","unstructured":"Gaskin DJ, Thorpe RJ Jr, McGinty EE, et al. Disparities in diabetes: the nexus of race, poverty, and place. Am J Public Health. 2014;104:2147\u201355. https:\/\/doi.org\/10.2105\/ajph.2013.301420.","journal-title":"Am J Public Health"},{"key":"1455_CR24","doi-asserted-by":"publisher","first-page":"3611","DOI":"10.2147\/dmso.S275898","volume":"13","author":"YT Wondmkun","year":"2020","unstructured":"Wondmkun YT. Obesity, insulin resistance, and type\u00a02 diabetes: associations and therapeutic implications. Diabetes Metab Syndr Obes. 2020;13:3611\u20136. https:\/\/doi.org\/10.2147\/dmso.S275898.","journal-title":"Diabetes Metab Syndr Obes"},{"key":"1455_CR25","doi-asserted-by":"publisher","DOI":"10.2337\/dc16-2099","author":"EK Ely","year":"2017","unstructured":"Ely EK, Gruss SM, Luman ET, et al. A national effort to prevent type\u00a02 diabetes: participant-level evaluation of CDC\u2019s National Diabetes Prevention Program. Diabetes Care. 2017. https:\/\/doi.org\/10.2337\/dc16-2099.","journal-title":"Diabetes Care"},{"key":"1455_CR26","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.116.025483","author":"RB Goldberg","year":"2017","unstructured":"Goldberg RB, Aroda VR, Bluemke DA, et al. Effect of long-term metformin and lifestyle in the diabetes prevention program and its outcome study on coronary artery calcium. Circulation. 2017. https:\/\/doi.org\/10.1161\/circulationaha.116.025483.","journal-title":"Circulation"},{"key":"1455_CR27","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1089\/pop.2021.0044","volume":"25","author":"J Williams","year":"2022","unstructured":"Williams J, Sachdev N, Kirley K, et al. Implementation of diabetes prevention in health care organizations: best practice recommendations. Popul Health Manag. 2022;25:31\u20138. https:\/\/doi.org\/10.1089\/pop.2021.0044.","journal-title":"Popul Health Manag"},{"key":"1455_CR28","doi-asserted-by":"publisher","first-page":"4095","DOI":"10.1007\/s11606-022-07522-4","volume":"37","author":"DC Dugdale","year":"2022","unstructured":"Dugdale DC, Khor S, Liao JM, Flum DR. Association between a population health intervention and hypertension control. J Gen Intern Med. 2022;37:4095\u2013102. https:\/\/doi.org\/10.1007\/s11606-022-07522-4.","journal-title":"J Gen Intern Med"},{"key":"1455_CR29","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s11606-022-07928-0","volume":"38","author":"JP Tanumihardjo","year":"2023","unstructured":"Tanumihardjo JP, Kuther S, Wan W, et al. New frontiers in diabetes care: quality improvement study of a population health team in rural critical access hospitals. J Gen Intern Med. 2023;38:56\u201364. https:\/\/doi.org\/10.1007\/s11606-022-07928-0.","journal-title":"J Gen Intern Med"},{"key":"1455_CR30","doi-asserted-by":"publisher","first-page":"2874","DOI":"10.2337\/dc07-0885","volume":"30","author":"TJ Hoerger","year":"2007","unstructured":"Hoerger TJ, Hicks KA, Sorensen SW, et al. Cost-effectiveness of screening for pre-diabetes among overweight and obese US adults. Diabetes Care. 2007;30:2874\u20139. https:\/\/doi.org\/10.2337\/dc07-0885.","journal-title":"Diabetes Care"},{"key":"1455_CR31","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.2337\/dc12-1752","volume":"36","author":"R Chatterjee","year":"2013","unstructured":"Chatterjee R, Narayan KM, Lipscomb J, et al. Screening for diabetes and prediabetes should be cost-saving in patients at high risk. Diabetes Care. 2013;36:1981\u20137. https:\/\/doi.org\/10.2337\/dc12-1752.","journal-title":"Diabetes Care"},{"key":"1455_CR32","first-page":"629","volume":"45","author":"ES Banerjee","year":"2013","unstructured":"Banerjee ES, Gambler A, Fogleman C. Adding obesity to the problem list increases the rate of providers addressing obesity. Fam Med. 2013;45:629\u201333.","journal-title":"Fam Med"},{"key":"1455_CR33","doi-asserted-by":"publisher","first-page":"283","DOI":"10.3122\/jabfm.2016.02.150252","volume":"29","author":"AG Mainous 3rd","year":"2016","unstructured":"Mainous AG 3rd, Tanner RJ, Baker R. Prediabetes diagnosis and treatment in primary care. J Am Board Fam Med. 2016;29:283\u20135. https:\/\/doi.org\/10.3122\/jabfm.2016.02.150252.","journal-title":"J Am Board Fam Med"},{"key":"1455_CR34","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1001\/jama.2021.12531","volume":"326","author":"KW Davidson","year":"2021","unstructured":"Davidson KW, Barry MJ, Mangione CM, et al. Screening for prediabetes and type\u00a02 diabetes: US preventive services task force recommendation statement. JAMA. 2021;326:736\u201343. https:\/\/doi.org\/10.1001\/jama.2021.12531.","journal-title":"JAMA"},{"key":"1455_CR35","doi-asserted-by":"publisher","first-page":"800","DOI":"10.2337\/dc16-2271","volume":"40","author":"E Svensson","year":"2017","unstructured":"Svensson E, Baggesen LM, Johnsen SP, et al. Early glycemic control and magnitude of HbA1c reduction predict cardiovascular events and mortality: population-based cohort study of 24,752 metformin initiators. Diabetes Care. 2017;40:800\u20137. https:\/\/doi.org\/10.2337\/dc16-2271.","journal-title":"Diabetes Care"},{"key":"1455_CR36","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.ahj.2013.01.005","volume":"165","author":"RR Giraldez","year":"2013","unstructured":"Giraldez RR, Clare RM, Lopes RD, et al. Prevalence and clinical outcomes of undiagnosed diabetes mellitus and prediabetes among patients with high-risk non-ST-segment elevation acute coronary syndrome. Am Heart J. 2013;165:918\u2013925.e912. https:\/\/doi.org\/10.1016\/j.ahj.2013.01.005.","journal-title":"Am Heart J"},{"key":"1455_CR37","doi-asserted-by":"publisher","first-page":"184","DOI":"10.2337\/dc10-0602","volume":"34","author":"RO Roberts","year":"2011","unstructured":"Roberts RO, Kantarci K, Geda YE, et al. Untreated type\u00a02 diabetes and its complications are associated with subcortical infarctions. Diabetes Care. 2011;34:184\u20136. https:\/\/doi.org\/10.2337\/dc10-0602.","journal-title":"Diabetes Care"},{"key":"1455_CR38","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","volume":"359","author":"RR Holman","year":"2008","unstructured":"Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type\u00a02 diabetes. N Engl J Med. 2008;359:1577\u201389. https:\/\/doi.org\/10.1056\/NEJMoa0806470.","journal-title":"N Engl J Med"},{"key":"1455_CR39","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/S0140-6736(98)07037-8","volume":"352","author":"UK Prospective Diabetes Study (UKPDS) Group","year":"1998","unstructured":"UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type\u00a02 diabetes (UKPDS 34). Lancet. 1998;352:854\u201365.","journal-title":"Lancet"},{"key":"1455_CR40","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","volume":"375","author":"SP Marso","year":"2016","unstructured":"Marso SP, Bain SC, Consoli A, et al. Semaglutide and cardiovascular outcomes in patients with type\u00a02 diabetes. N Engl J Med. 2016;375:1834\u201344. https:\/\/doi.org\/10.1056\/NEJMoa1607141.","journal-title":"N Engl J Med"},{"key":"1455_CR41","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/s0140-6736(19)31149-3","volume":"394","author":"HC Gerstein","year":"2019","unstructured":"Gerstein HC, Colhoun HM, Dagenais GR, et al. Dulaglutide and cardiovascular outcomes in type\u00a02 diabetes (REWIND): a double-blind, randomised placebo-controlled trial. Lancet. 2019;394:121\u201330. https:\/\/doi.org\/10.1016\/s0140-6736(19)31149-3.","journal-title":"Lancet"},{"key":"1455_CR42","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1056\/NEJMoa1603827","volume":"375","author":"SP Marso","year":"2016","unstructured":"Marso SP, Daniels GH, Brown-Frandsen K, et al. Liraglutide and cardiovascular outcomes in type\u00a02 diabetes. N Engl J Med. 2016;375:311\u201322. https:\/\/doi.org\/10.1056\/NEJMoa1603827.","journal-title":"N Engl J Med"},{"key":"1455_CR43","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","volume":"373","author":"B Zinman","year":"2015","unstructured":"Zinman B, Wanner C, Lachin JM, et al. Empagliflozin, cardiovascular outcomes, and mortality in type\u00a02 diabetes. N Engl J Med. 2015;373:2117\u201328. https:\/\/doi.org\/10.1056\/NEJMoa1504720.","journal-title":"N Engl J Med"},{"key":"1455_CR44","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1056\/NEJMoa1611925","volume":"377","author":"B Neal","year":"2017","unstructured":"Neal B, Perkovic V, Mahaffey KW, et al. Canagliflozin and cardiovascular and renal events in type\u00a02 diabetes. N Engl J Med. 2017;377:644\u201357. https:\/\/doi.org\/10.1056\/NEJMoa1611925.","journal-title":"N Engl J Med"},{"key":"1455_CR45","doi-asserted-by":"publisher","first-page":"S102","DOI":"10.1161\/01.cir.0000437739.71477.ee","volume":"129","author":"MD Jensen","year":"2014","unstructured":"Jensen MD, Ryan DH, Apovian CM, et al. 2013 AHA\/ACC\/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation. 2014;129:S102\u2013138. https:\/\/doi.org\/10.1161\/01.cir.0000437739.71477.ee.","journal-title":"Circulation"},{"key":"1455_CR46","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12933-019-0900-7","volume":"18","author":"Y Han","year":"2019","unstructured":"Han Y, Xie H, Liu Y, Gao P, Yang X, Shen Z. Effect of metformin on all-cause and cardiovascular mortality in patients with coronary artery diseases: a systematic review and an updated meta-analysis. Cardiovasc Diabetol. 2019;18:96. https:\/\/doi.org\/10.1186\/s12933-019-0900-7.","journal-title":"Cardiovasc Diabetol"},{"key":"1455_CR47","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1056\/NEJMoa1010949","volume":"364","author":"RA DeFronzo","year":"2011","unstructured":"DeFronzo RA, Tripathy D, Schwenke DC, et al. Pioglitazone for diabetes prevention in impaired glucose tolerance. N Engl J Med. 2011;364:1104\u201315. https:\/\/doi.org\/10.1056\/NEJMoa1010949.","journal-title":"N Engl J Med"},{"key":"1455_CR48","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1506930","author":"WN Kernan","year":"2016","unstructured":"Kernan WN, Viscoli CM, Furie KL, et al. Pioglitazone after ischemic stroke or transient ischemic attack. N Engl J Med. 2016. https:\/\/doi.org\/10.1056\/NEJMoa1506930.","journal-title":"N Engl J Med"},{"key":"1455_CR49","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1016\/s0140-6736(17)30069-7","volume":"389","author":"CW le Roux","year":"2017","unstructured":"le Roux CW, Astrup A, Fujioka K, et al. 3\u00a0years of liraglutide versus placebo for type\u00a02 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial. Lancet. 2017;389:1399\u2013409. https:\/\/doi.org\/10.1016\/s0140-6736(17)30069-7.","journal-title":"Lancet"},{"key":"1455_CR50","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2032183","author":"JPH Wilding","year":"2021","unstructured":"Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021. https:\/\/doi.org\/10.1056\/NEJMoa2032183.","journal-title":"N Engl J Med"},{"key":"1455_CR51","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.2337\/dc16-0873","volume":"39","author":"WT Cefalu","year":"2016","unstructured":"Cefalu WT, Buse JB, Tuomilehto J, et al. Update and next steps for real-world translation of interventions for type\u00a02 diabetes prevention: reflections from a diabetes care editors\u2019 expert forum. Diabetes Care. 2016;39:1186\u2013201. https:\/\/doi.org\/10.2337\/dc16-0873.","journal-title":"Diabetes Care"},{"key":"1455_CR52","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1016\/s0140-6736(12)60283-9","volume":"379","author":"AG Tab\u00e1k","year":"2012","unstructured":"Tab\u00e1k AG, Herder C, Rathmann W, Brunner EJ, Kivim\u00e4ki M. Prediabetes: a high-risk state for diabetes development. Lancet. 2012;379:2279\u201390. https:\/\/doi.org\/10.1016\/s0140-6736(12)60283-9.","journal-title":"Lancet"},{"key":"1455_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/s2213-8587(18)30027-5","author":"MK Ali","year":"2018","unstructured":"Ali MK, Bullard KM, Saydah S, Imperatore G, Gregg EW. Cardiovascular and renal burdens of prediabetes in the USA: analysis of data from serial cross-sectional surveys, 1988\u20132014. Lancet Diabetes Endocrinol. 2018. https:\/\/doi.org\/10.1016\/s2213-8587(18)30027-5.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1455_CR54","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m2297","volume":"370","author":"X Cai","year":"2020","unstructured":"Cai X, Zhang Y, Li M, et al. Association between prediabetes and risk of all cause mortality and cardiovascular disease: updated meta-analysis. BMJ. 2020;370: m2297. https:\/\/doi.org\/10.1136\/bmj.m2297.","journal-title":"BMJ"},{"key":"1455_CR55","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1111\/dom.14388","volume":"23","author":"X Cai","year":"2021","unstructured":"Cai X, Liu X, Sun L, et al. Prediabetes and the risk of heart failure: a meta-analysis. Diabetes Obes Metab. 2021;23:1746\u201353. https:\/\/doi.org\/10.1111\/dom.14388.","journal-title":"Diabetes Obes Metab"},{"key":"1455_CR56","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.eprac.2021.10.004","volume":"28","author":"NW Carris","year":"2022","unstructured":"Carris NW, Corvin JA. Prediabetes: an undiagnosed pandemic. Endocr Pract. 2022;28:231\u20132. https:\/\/doi.org\/10.1016\/j.eprac.2021.10.004.","journal-title":"Endocr Pract"},{"key":"1455_CR57","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1001\/jama.2021.16685","volume":"326","author":"A Ellison-Barnes","year":"2021","unstructured":"Ellison-Barnes A, Johnson S, Gudzune K. Trends in obesity prevalence among adults aged 18 through 25\u00a0years, 1976\u20132018. JAMA. 2021;326:2073\u20134. https:\/\/doi.org\/10.1001\/jama.2021.16685.","journal-title":"JAMA"},{"key":"1455_CR58","unstructured":"Hales CM, Carroll MD, Fryar CD, Ogden CL. Prevalence of obesity and severe obesity among adults: United States, 2017\u20132018. NCHS Data Brief, no 360. Hyattsville, MD: National Center for Health Statistics. 2020."},{"key":"1455_CR59","unstructured":"Centers for Disease Control and Prevention. National Diabetes Statistics Report website. https:\/\/www.cdc.gov\/diabetes\/data\/statistics-report\/index.html. Accessed 28 Jun 2023."},{"key":"1455_CR60","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1001\/jamainternmed.2016.5394","volume":"176","author":"CE Kearns","year":"2016","unstructured":"Kearns CE, Schmidt LA, Glantz SA. Sugar industry and coronary heart disease research: a historical analysis of internal industry documents. JAMA Intern Med. 2016;176:1680\u20135. https:\/\/doi.org\/10.1001\/jamainternmed.2016.5394.","journal-title":"JAMA Intern Med"},{"key":"1455_CR61","doi-asserted-by":"publisher","first-page":"901","DOI":"10.3945\/ajcn.114.089458","volume":"100","author":"A Drewnowski","year":"2014","unstructured":"Drewnowski A, Rehm CD. Consumption of added sugars among US children and adults by food purchase location and food source. Am J Clin Nutr. 2014;100:901\u20137. https:\/\/doi.org\/10.3945\/ajcn.114.089458.","journal-title":"Am J Clin Nutr"},{"key":"1455_CR62","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.9778\/cmajo.20160076","volume":"5","author":"RB Acton","year":"2017","unstructured":"Acton RB, Vanderlee L, Hobin EP, Hammond D. Added sugar in the packaged foods and beverages available at a major Canadian retailer in 2015: a descriptive analysis. CMAJ Open. 2017;5:E1\u2013E6. https:\/\/doi.org\/10.9778\/cmajo.20160076.","journal-title":"CMAJ Open"},{"key":"1455_CR63","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1001\/jamainternmed.2013.13563","volume":"174","author":"Q Yang","year":"2014","unstructured":"Yang Q, Zhang Z, Gregg EW, Flanders WD, Merritt R, Hu FB. Added sugar intake and cardiovascular diseases mortality among US adults. JAMA Intern Med. 2014;174:516\u201324. https:\/\/doi.org\/10.1001\/jamainternmed.2013.13563.","journal-title":"JAMA Intern Med"},{"key":"1455_CR64","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.cities.2018.03.003","volume":"79","author":"C Li","year":"2018","unstructured":"Li C, Ghiasi A, Li X, Chi G. Sociodemographics and access to organic and local food: a case study of New Orleans Louisiana. Cities. 2018;79:141\u201350. https:\/\/doi.org\/10.1016\/j.cities.2018.03.003.","journal-title":"Cities"},{"key":"1455_CR65","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s40795-021-00434-2","volume":"7","author":"G Sansom","year":"2021","unstructured":"Sansom G, Hannibal B. Disparate access to nutritional food; place, race and equity in the United States. BMC Nutr. 2021;7:29. https:\/\/doi.org\/10.1186\/s40795-021-00434-2.","journal-title":"BMC Nutr"},{"key":"1455_CR66","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0257288","volume":"16","author":"RR Gundala","year":"2021","unstructured":"Gundala RR, Singh A. What motivates consumers to buy organic foods? Results of an empirical study in the United States. PLoS ONE. 2021;16: e0257288. https:\/\/doi.org\/10.1371\/journal.pone.0257288.","journal-title":"PLoS ONE"},{"key":"1455_CR67","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1111\/jdi.13935","volume":"14","author":"BT Zeng","year":"2023","unstructured":"Zeng BT, Pan HQ, Li FD, Ye ZY, Liu Y, Du JW. Comparative efficacy of different eating patterns in the management of type\u00a02 diabetes and prediabetes: an arm-based Bayesian network meta-analysis. J Diabetes Investig. 2023;14:263\u201388. https:\/\/doi.org\/10.1111\/jdi.13935.","journal-title":"J Diabetes Investig"},{"key":"1455_CR68","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.2337\/dc19-1708","volume":"43","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Tan H, Tang J, et al. Effects of vitamin D supplementation on prevention of type\u00a02 diabetes in patients with prediabetes: a systematic review and meta-analysis. Diabetes Care. 2020;43:1650\u20138. https:\/\/doi.org\/10.2337\/dc19-1708.","journal-title":"Diabetes Care"},{"key":"1455_CR69","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003053","volume":"17","author":"AN Reynolds","year":"2020","unstructured":"Reynolds AN, Akerman AP, Mann J. Dietary fibre and whole grains in diabetes management: systematic review and meta-analyses. PLoS Med. 2020;17:e1003053. https:\/\/doi.org\/10.1371\/journal.pmed.1003053.","journal-title":"PLoS Med"},{"key":"1455_CR70","doi-asserted-by":"publisher","DOI":"10.3390\/nu13093193","author":"TT Hansen","year":"2021","unstructured":"Hansen TT, Astrup A, Sj\u00f6din A. Are dietary proteins the key to successful body weight management? A systematic review and meta-analysis of studies assessing body weight outcomes after interventions with increased dietary protein. Nutrients. 2021. https:\/\/doi.org\/10.3390\/nu13093193.","journal-title":"Nutrients"},{"key":"1455_CR71","doi-asserted-by":"publisher","first-page":"1112920","DOI":"10.3389\/fped.2023.1112920","volume":"11","author":"JL Clasey","year":"2023","unstructured":"Clasey JL, Easley EA, Murphy MO, et al. Body mass index percentiles versus body composition assessments: challenges for disease risk classifications in children. Front Pediatr. 2023;11:1112920. https:\/\/doi.org\/10.3389\/fped.2023.1112920.","journal-title":"Front Pediatr"},{"key":"1455_CR72","unstructured":"Endocrine Society. BMI alone may not be a sufficient indicator of metabolic health. https:\/\/www.endocrine.org\/news-and-advocacy\/news-room\/2023\/endo-2023-press-visaria. Accessed 21 Jun 2023."},{"key":"1455_CR73","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2019.4498","volume":"174","author":"LJ Andes","year":"2020","unstructured":"Andes LJ, Cheng YJ, Rolka DB, Gregg EW, Imperatore G. Prevalence of prediabetes among adolescents and young adults in the United States, 2005\u20132016. JAMA Pediatr. 2020;174: e194498. https:\/\/doi.org\/10.1001\/jamapediatrics.2019.4498.","journal-title":"JAMA Pediatr"},{"key":"1455_CR74","doi-asserted-by":"publisher","DOI":"10.1177\/2333794x19891305","author":"A Sanyaolu","year":"2019","unstructured":"Sanyaolu A, Okorie C, Qi X, Locke J, Rehman S. Childhood and adolescent obesity in the United States: a public health concern. Glob Pediatr Health. 2019. https:\/\/doi.org\/10.1177\/2333794x19891305.","journal-title":"Glob Pediatr Health"},{"key":"1455_CR75","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/s2352-4642(21)00204-2","volume":"5","author":"HS Badesha","year":"2021","unstructured":"Badesha HS, Bagri G, Nagra A, Nijran K, Singh G, Aiyegbusi OL. Tackling childhood overweight and obesity after the COVID-19 pandemic. Lancet Child Adolesc Health. 2021;5:687\u20138. https:\/\/doi.org\/10.1016\/s2352-4642(21)00204-2.","journal-title":"Lancet Child Adolesc Health"},{"key":"1455_CR76","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.29348","volume":"14","author":"S Jha","year":"2022","unstructured":"Jha S, Mehendale AM. Increased incidence of obesity in children and adolescents post-COVID-19 pandemic: a review article. Cureus. 2022;14: e29348. https:\/\/doi.org\/10.7759\/cureus.29348.","journal-title":"Cureus"},{"key":"1455_CR77","unstructured":"Endocrine Society. Type\u00a02 diabetes increased among youth during and after COVID-19 pandemic. https:\/\/www.endocrine.org\/news-and-advocacy\/news-room\/2023\/endo-2023-press-bell-sambataro. Accessed 21 Jun 2023."},{"key":"1455_CR78","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1001\/jamapediatrics.2019.1759","volume":"173","author":"E Boers","year":"2019","unstructured":"Boers E, Afzali MH, Newton N, Conrod P. Association of screen time and depression in adolescence. JAMA Pediatr. 2019;173:853\u20139. https:\/\/doi.org\/10.1001\/jamapediatrics.2019.1759.","journal-title":"JAMA Pediatr"},{"key":"1455_CR79","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0157240","volume":"11","author":"M Mannan","year":"2016","unstructured":"Mannan M, Mamun A, Doi S, Clavarino A. Prospective associations between depression and obesity for adolescent males and females\u2014a systematic review and meta-analysis of longitudinal studies. PLoS ONE. 2016;11: e0157240. https:\/\/doi.org\/10.1371\/journal.pone.0157240.","journal-title":"PLoS ONE"},{"key":"1455_CR80","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1377\/hlthaff.2011.1009","volume":"31","author":"MK Ali","year":"2012","unstructured":"Ali MK, Echouffo-Tcheugui J, Williamson DF. How effective were lifestyle interventions in real-world settings that were modeled on the Diabetes Prevention Program? Health Aff (Millwood). 2012;31:67\u201375. https:\/\/doi.org\/10.1377\/hlthaff.2011.1009.","journal-title":"Health Aff (Millwood)"},{"key":"1455_CR81","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0265913","volume":"17","author":"RM Ferreira Silva","year":"2022","unstructured":"Ferreira Silva RM, Mendon\u00e7a CR, Azevedo VD, Raoof Memon A, Noll P, Noll M. Barriers to high school and university students\u2019 physical activity: a systematic review. PLoS ONE. 2022;17: e0265913. https:\/\/doi.org\/10.1371\/journal.pone.0265913.","journal-title":"PLoS ONE"},{"key":"1455_CR82","doi-asserted-by":"publisher","DOI":"10.3389\/fspor.2022.789259","volume":"4","author":"S Nally","year":"2022","unstructured":"Nally S, Ridgers ND, Gallagher AM, Murphy MH, Salmon J, Carlin A. \u201cWhen you move you have fun\u201d: perceived barriers, and facilitators of physical activity from a child\u2019s perspective. Front Sports Act Living. 2022;4: 789259. https:\/\/doi.org\/10.3389\/fspor.2022.789259.","journal-title":"Front Sports Act Living"},{"key":"1455_CR83","first-page":"39","volume":"11","author":"HE Yungblut","year":"2012","unstructured":"Yungblut HE, Schinke RJ, McGannon KR. Views of adolescent female youth on physical activity during early adolescence. J Sports Sci Med. 2012;11:39\u201350.","journal-title":"J Sports Sci Med"},{"key":"1455_CR84","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1123\/jpah.2017-0218","volume":"15","author":"P Abi Nader","year":"2018","unstructured":"Abi Nader P, Hilberg E, Schuna JM, John DH, Gunter KB. Teacher-level factors, classroom physical activity opportunities, and children\u2019s physical activity levels. J Phys Act Health. 2018;15:637\u201343. https:\/\/doi.org\/10.1123\/jpah.2017-0218.","journal-title":"J Phys Act Health"},{"key":"1455_CR85","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12966-021-01129-4","volume":"18","author":"A Pulling Kuhn","year":"2021","unstructured":"Pulling Kuhn A, Kim E, Lane HG, et al. Associations between elementary and middle school teachers\u2019 physical activity promoting practices and teacher- and school-level factors. Int J Behav Nutr Phys Act. 2021;18:66. https:\/\/doi.org\/10.1186\/s12966-021-01129-4.","journal-title":"Int J Behav Nutr Phys Act"},{"key":"1455_CR86","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1177\/1090198117731600","volume":"45","author":"RG Weaver","year":"2018","unstructured":"Weaver RG, Webster CA, Beets MW, et al. Initial outcomes of a participatory-based, competency-building approach to increasing physical education teachers\u2019 physical activity promotion and students\u2019 physical activity: a pilot study. Health Educ Behav. 2018;45:359\u201370. https:\/\/doi.org\/10.1177\/1090198117731600.","journal-title":"Health Educ Behav"},{"key":"1455_CR87","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0231924","volume":"15","author":"J Gao","year":"2020","unstructured":"Gao J, Zheng P, Jia Y, et al. Mental health problems and social media exposure during COVID-19 outbreak. PLoS ONE. 2020;15: e0231924. https:\/\/doi.org\/10.1371\/journal.pone.0231924.","journal-title":"PLoS ONE"},{"key":"1455_CR88","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0228585","volume":"15","author":"Y Wang","year":"2020","unstructured":"Wang Y, Lynne SD, Witherspoon D, Black MM. Longitudinal bidirectional relations between body dissatisfaction and depressive symptoms among Black adolescents: a cross-lagged panel analysis. PLoS ONE. 2020;15:e0228585. https:\/\/doi.org\/10.1371\/journal.pone.0228585.","journal-title":"PLoS ONE"},{"key":"1455_CR89","doi-asserted-by":"publisher","DOI":"10.1136\/bmjsem-2020-000832","volume":"6","author":"V Huard Pelletier","year":"2020","unstructured":"Huard Pelletier V, Lessard A, Pich\u00e9 F, T\u00e9treau C, Descarreaux M. Video games and their associations with physical health: a scoping review. BMJ Open Sport Exerc Med. 2020;6: e000832. https:\/\/doi.org\/10.1136\/bmjsem-2020-000832.","journal-title":"BMJ Open Sport Exerc Med"},{"key":"1455_CR90","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpr.2022.102128","volume":"92","author":"SQ Meng","year":"2022","unstructured":"Meng SQ, Cheng JL, Li YY, et al. Global prevalence of digital addiction in general population: a systematic review and meta-analysis. Clin Psychol Rev. 2022;92: 102128. https:\/\/doi.org\/10.1016\/j.cpr.2022.102128.","journal-title":"Clin Psychol Rev"},{"key":"1455_CR91","doi-asserted-by":"publisher","first-page":"298","DOI":"10.3389\/fnhum.2020.00298","volume":"14","author":"S Hamidullah","year":"2020","unstructured":"Hamidullah S, Thorpe HHA, Frie JA, McCurdy RD, Khokhar JY. Adolescent substance use and the brain: behavioral, cognitive and neuroimaging correlates. Front Hum Neurosci. 2020;14:298. https:\/\/doi.org\/10.3389\/fnhum.2020.00298.","journal-title":"Front Hum Neurosci"},{"key":"1455_CR92","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1177\/1559827619892543","volume":"14","author":"AB Cepni","year":"2020","unstructured":"Cepni AB, Ledoux TA, Johnston CA. Screen media: a powerful reinforcement. Am J Lifestyle Med. 2020;14:126\u20139. https:\/\/doi.org\/10.1177\/1559827619892543.","journal-title":"Am J Lifestyle Med"},{"key":"1455_CR93","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1151\/spp021113","volume":"1","author":"TR Kosten","year":"2002","unstructured":"Kosten TR, George TP. The neurobiology of opioid dependence: implications for treatment. Sci Pract Perspect. 2002;1:13\u201320. https:\/\/doi.org\/10.1151\/spp021113.","journal-title":"Sci Pract Perspect"},{"key":"1455_CR94","doi-asserted-by":"publisher","first-page":"635","DOI":"10.2105\/ajph.93.4.635","volume":"93","author":"KS Yarnall","year":"2003","unstructured":"Yarnall KS, Pollak KI, \u00d8stbye T, Krause KM, Michener JL. Primary care: is there enough time for prevention? Am J Public Health. 2003;93:635\u201341. https:\/\/doi.org\/10.2105\/ajph.93.4.635.","journal-title":"Am J Public Health"},{"key":"1455_CR95","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1056\/NEJMoa1600869","volume":"376","author":"PR Schauer","year":"2017","unstructured":"Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric surgery versus intensive medical therapy for diabetes\u20145-year outcomes. N Engl J Med. 2017;376:641\u201351. https:\/\/doi.org\/10.1056\/NEJMoa1600869.","journal-title":"N Engl J Med"},{"key":"1455_CR96","unstructured":"Eli Lilly and Company. A study of tirzepatide (LY3298176) on the reduction on morbidity and mortality in adults with obesity (SURMOUNT-MMO). ClinicalTrials.gov Identifier: NCT05556512. https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT05556512. Accessed 12 Jul 2023."},{"key":"1455_CR97","doi-asserted-by":"publisher","first-page":"e76","DOI":"10.1161\/cir.0000000000001124","volume":"147","author":"SS Khan","year":"2023","unstructured":"Khan SS, Brewer LC, Canobbio MM, et al. Optimizing prepregnancy cardiovascular health to improve outcomes in pregnant and postpartum individuals and offspring: a scientific statement from the American Heart Association. Circulation. 2023;147:e76\u201391. https:\/\/doi.org\/10.1161\/cir.0000000000001124.","journal-title":"Circulation"},{"key":"1455_CR98","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1016\/s0140-6736(23)01296-5","volume":"401","author":"T Lancet","year":"2023","unstructured":"Lancet T. Diabetes: a defining disease of the 21st century. Lancet. 2023;401:2087. https:\/\/doi.org\/10.1016\/s0140-6736(23)01296-5.","journal-title":"Lancet"}],"container-title":["Diabetes Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-023-01455-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13300-023-01455-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-023-01455-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T05:16:18Z","timestamp":1694582178000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13300-023-01455-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,5]]},"references-count":98,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["1455"],"URL":"https:\/\/doi.org\/10.1007\/s13300-023-01455-9","relation":{},"ISSN":["1869-6953","1869-6961"],"issn-type":[{"value":"1869-6953","type":"print"},{"value":"1869-6961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,5]]},"assertion":[{"value":"30 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}